BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2017
View Archived Issues
Otsuka Pharmaceutical recaps highlights of first quarter 2017
Read More
LV.CD11b.IDS for the treatment of neurocognitive impairments in an MPS II mouse model
Read More
FDA places CTP-543 phase IIa study on hold
Read More
Shire initiates phase I study of SHP-639 in intraocular hypertension and primary open-angle glaucoma
Read More
Promising clinical results seen with AAV2-AADC for AADC deficiency
Read More
rAAV9-CBA-hNAGLUop optimized gene delivery for treating MPS IIIB
Read More
FDA approves Kalydeco to treat cystic fibrosis in patients with certain residual function mutations
Read More
Omeros provides update on phase II study of OMS-721
Read More
Bristol-Myers Squibb patents casein kinase II inhibitors
Read More
Vifor presents ferroportin inhibitors
Read More
Aurinia initiates phase III study of voclosporin for lupus nephritis
Read More
Quanterix launches Simoa Neurology 4-Plex A assay to study traumatic brain injury severity
Read More
Heptares Therapeutics identifies calcitonin gene-related peptides receptor antagonists
Read More
FDA grants breakthrough therapy designation to GMI-1271 for relapsed or refractory AML
Read More
Merck & Co. discovers coagulation factor XIa and kallikrein inhibitors
Read More
Sun Pharma Advanced Research discloses estrogen receptor antagonists
Read More
Aduro Biotech expands clinical collaboration with Merck & Co.
Read More
Nanobiotix reports clinical data on potential role of NBTXR-3 in immuno-oncology
Read More
Teva nominates preclinical candidate CGRP antagonist for advancement to treat migraine
Read More
NC16A IgG4 may be a serum diagnostic marker of eosinophilic esophagitis
Read More
Specialised Therapeutics and PharmaMar enter lurbinectedin licensing agreement
Read More
miR-155 found as a predictor of methotrexate nonresponse in rheumatoid arthritis patients
Read More
Evaluation of novel anti-MUC1 (CAR)-modified T cells for the treatment of breast cancer
Read More
